16:09 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences filed its Reg 32 statement of IPO fund utilisation for the half-year to September 30, 2026. The filing reports no deviation or variation, with ₹2,295.11 lakhs utilised against ₹2,752 lakhs proposed.